438 related articles for article (PubMed ID: 16723576)
1. Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus.
Friedman L; Alder JD; Silverman JA
Antimicrob Agents Chemother; 2006 Jun; 50(6):2137-45. PubMed ID: 16723576
[TBL] [Abstract][Full Text] [Related]
2. Gain-of-Function Mutations in the Phospholipid Flippase MprF Confer Specific Daptomycin Resistance.
Ernst CM; Slavetinsky CJ; Kuhn S; Hauser JN; Nega M; Mishra NN; Gekeler C; Bayer AS; Peschel A
mBio; 2018 Dec; 9(6):. PubMed ID: 30563904
[TBL] [Abstract][Full Text] [Related]
3. Daptomycin nonsusceptibility in Staphylococcus aureus with reduced vancomycin susceptibility is independent of alterations in MprF.
Pillai SK; Gold HS; Sakoulas G; Wennersten C; Moellering RC; Eliopoulos GM
Antimicrob Agents Chemother; 2007 Jun; 51(6):2223-5. PubMed ID: 17404001
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of resistance to daptomycin in Staphylococcus aureus.
Gómez Casanova N; Siller Ruiz M; Muñoz Bellido JL
Rev Esp Quimioter; 2017 Dec; 30(6):391-396. PubMed ID: 29082727
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of in-vitro-selected daptomycin-non-susceptibility in Staphylococcus aureus.
Patel D; Husain M; Vidaillac C; Steed ME; Rybak MJ; Seo SM; Kaatz GW
Int J Antimicrob Agents; 2011 Nov; 38(5):442-6. PubMed ID: 21840181
[TBL] [Abstract][Full Text] [Related]
6. Daptomycin: mechanisms of action and resistance, and biosynthetic engineering.
Baltz RH
Curr Opin Chem Biol; 2009 Apr; 13(2):144-51. PubMed ID: 19303806
[TBL] [Abstract][Full Text] [Related]
7. Stepwise decrease in daptomycin susceptibility in clinical Staphylococcus aureus isolates associated with an initial mutation in rpoB and a compensatory inactivation of the clpX gene.
Bæk KT; Thøgersen L; Mogenssen RG; Mellergaard M; Thomsen LE; Petersen A; Skov S; Cameron DR; Peleg AY; Frees D
Antimicrob Agents Chemother; 2015 Nov; 59(11):6983-91. PubMed ID: 26324273
[TBL] [Abstract][Full Text] [Related]
8. Regulation of mprF by antisense RNA restores daptomycin susceptibility to daptomycin-resistant isolates of Staphylococcus aureus.
Rubio A; Conrad M; Haselbeck RJ; G C K; Brown-Driver V; Finn J; Silverman JA
Antimicrob Agents Chemother; 2011 Jan; 55(1):364-7. PubMed ID: 20974866
[TBL] [Abstract][Full Text] [Related]
9. Impact of daptomycin resistance on Staphylococcus aureus virulence.
Cameron DR; Mortin LI; Rubio A; Mylonakis E; Moellering RC; Eliopoulos GM; Peleg AY
Virulence; 2015; 6(2):127-31. PubMed ID: 25830650
[TBL] [Abstract][Full Text] [Related]
10. Prolonged Exposure to β-Lactam Antibiotics Reestablishes Susceptibility of Daptomycin-Nonsusceptible Staphylococcus aureus to Daptomycin.
Jenson RE; Baines SL; Howden BP; Mishra NN; Farah S; Lew C; Berti AD; Shukla SK; Bayer AS; Rose WE
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32601160
[TBL] [Abstract][Full Text] [Related]
11. LC-MS/MS characterization of phospholipid content in daptomycin-susceptible and -resistant isolates of Staphylococcus aureus with mutations in mprF.
Rubio A; Moore J; Varoglu M; Conrad M; Chu M; Shaw W; Silverman JA
Mol Membr Biol; 2012 Feb; 29(1):1-8. PubMed ID: 22276671
[TBL] [Abstract][Full Text] [Related]
12. Whole-genome sequencing identifies MprF mutations in a genetically diverse population of daptomycin non-susceptible Staphylococcus aureus in Australia.
Lim C; Coombs GW; Daley DA; Shoby P; Mowlaboccus S
Int J Antimicrob Agents; 2024 May; 63(5):107144. PubMed ID: 38494147
[TBL] [Abstract][Full Text] [Related]
13. Impact of Multiple Single-Nucleotide Polymorphisms Within mprF on Daptomycin Resistance in Staphylococcus aureus.
Yang SJ; Mishra NN; Kang KM; Lee GY; Park JH; Bayer AS
Microb Drug Resist; 2018 Oct; 24(8):1075-1081. PubMed ID: 29381428
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility profiles of meticillin-susceptible and -resistant Staphylococcus aureus: focus on daptomycin minimum inhibitory concentrations at a tertiary care centre in Mumbai, India.
D'Souza N; Shetty A; Mehta A; Rodrigues C
Int J Antimicrob Agents; 2010 Sep; 36(3):267-70. PubMed ID: 20594809
[TBL] [Abstract][Full Text] [Related]
15. Regulation of mprF in daptomycin-nonsusceptible Staphylococcus aureus strains.
Yang SJ; Xiong YQ; Dunman PM; Schrenzel J; François P; Peschel A; Bayer AS
Antimicrob Agents Chemother; 2009 Jun; 53(6):2636-7. PubMed ID: 19289517
[TBL] [Abstract][Full Text] [Related]
16. Defective
Freeman CD; Hansen T; Urbauer R; Wilkinson BJ; Singh VK; Hines KM
mSphere; 2024 Jun; 9(6):e0011524. PubMed ID: 38752757
[TBL] [Abstract][Full Text] [Related]
17. Daptomycin resistance in methicillin-resistant Staphylococcus aureus is conferred by IS256 insertion in the promoter of mprF along with mutations in mprF and walK.
Yin Y; Chen H; Li S; Gao H; Sun S; Li H; Wang R; Jin L; Liu Y; Wang H
Int J Antimicrob Agents; 2019 Dec; 54(6):673-680. PubMed ID: 31479743
[TBL] [Abstract][Full Text] [Related]
18. An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus.
Cui L; Isii T; Fukuda M; Ochiai T; Neoh HM; Camargo IL; Watanabe Y; Shoji M; Hishinuma T; Hiramatsu K
Antimicrob Agents Chemother; 2010 Dec; 54(12):5222-33. PubMed ID: 20837752
[TBL] [Abstract][Full Text] [Related]
19. Causal role of single nucleotide polymorphisms within the mprF gene of Staphylococcus aureus in daptomycin resistance.
Yang SJ; Mishra NN; Rubio A; Bayer AS
Antimicrob Agents Chemother; 2013 Nov; 57(11):5658-64. PubMed ID: 24002096
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of genetic pathways toward daptomycin nonsusceptibility in Staphylococcus aureus determined by adjunctive antibiotics.
Berti AD; Baines SL; Howden BP; Sakoulas G; Nizet V; Proctor RA; Rose WE
Antimicrob Agents Chemother; 2015 May; 59(5):2799-806. PubMed ID: 25733508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
